We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NVCR

Price
12.82
Stock movement down
-0.66 (-4.90%)
Company name
Novocure Ltd
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
1.43B
Ent value
2.11B
Price/Sales
2.48
Price/Book
3.97
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
22.97%
1 year return
-22.86%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

DIVIDENDS

NVCR does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.48
Price to Book3.97
EV to Sales3.65

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count111.80M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-1.51

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash344.64M
Net receivables85.23M
Total current assets1.20B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets1.36B
Accounts payable118.92M
Short/Current long term debt797.94M
Total current liabilities776.01M
Total liabilities1.02B
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open13.48
Daily high14.22
Daily low12.73
Daily Volume2.22M
All-time high225.58
1y analyst estimate24.69
Beta0.83
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
NVCRS&P500
Current price drop from All-time high-94.32%-1.10%
Highest price drop-95.17%-19.00%
Date of highest drop11 Aug 20258 Apr 2025
Avg drop from high-91.89%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
NVCR (Novocure Ltd) company logo
Marketcap
1.43B
Marketcap category
Small-cap
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Employees
1488
Investor relations
-
SEC filings
CEO
Asaf Danziger
Country
USA
City
St. Helier
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...